Clinnovate Health UK Ltd is the first life sciences company from Singapore to invest in Scotland, bringing its Genesis Imaging Services (GIS) lab to Glasgow as Scotland's Imaging Centre of Excellence opens at Queen Elizabeth University Hospital.
Clinnovate Health offers histology and genomics services for the clinical research market in areas of fibrosis and cancer.
The Singapore company will test and develop its kidney imaging system for transplant histological assessment at its laboratory in University of Glasgow's new Imaging Centre of Excellence opened at Glasgow's Queen Elizabeth University Hospital.
We are excited to be located at the heart of the Precision Medicine Ecosystem within the University of Glasgow.
Serene Lek, CEO Clinnovate Health UK Ltd
"We are excited to be located at the heart of the Precision Medicine Ecosystem within the University of Glasgow. We see great synergy with the various entities, given that we focus on both integrative diagnostics and personalised treatment." commented Serene Lek, CEO of Clinnovate Health UK Ltd.
"It has since helped us to accelerate partnerships with a number of groups within Scotland and the NHS who are carrying out clinical research into cancer, fibrosis and kidney transplantation.“
Growing international collaboration
Linda Hanna, Scottish Enterprise's Head of Strategy and Sectors, is clear about what is attracting companies like Clinnovate to Scotland. "Our world-class expertise in Life Sciences is becoming increasingly acknowledged on the global stage and Clinnovate Health's decision to invest in Scotland is a further testament to this.
"Scotland and Singapore are both regarded as world leading centres for biomedical research and it is great to see growing interest in collaboration between our two countries. As part of Glasgow University's Imaging Centre for Excellence, Clinnovate Health will be at the forefront of medical innovation and we look forward to continuing to support its growth within Scotland."
New imaging powers
The new Imaging Centre of Excellence (ICE) incorporates a 7 Tesla MRI scanner, an ultra-high resolution scanner, the first of its kind fully integrated within a clinical site in the UK.
The ICE provides specialist infrastructure to drive healthcare innovation at QEUH, including space dedicated for biomedical companies. This Clinical Innovation Zone , which totals 22,000 sq ft and is now recognised as a UKSPA Science Park, sits alongside our world-leading clinical academic research and state-of-the-art Clinical Research Facilities for precision medicine clinical trials.
Want to discuss a project or find out how we can help?
Get in touch
The Clinical Innovation Zone has already attracted international small and medium-size enterprises (SMEs) from around the world, including Germany and, now, Singapore.
The ICE will link to, and add significant value to the University's adjacent Phase 1 research imaging developments within the Queen Elizabeth University Hospital campus. This will include 3T MRI and CT scanners, transforming our capacity to deliver leadership internationally in imaging and precision medicine.
Building capacity for precision medicine
The ICE will also accommodate clinical academic imaging specialists, neuroscientists, engineers, bioinformaticians and NHS clinical physics expertise, and provide future expansion space for precision medicine activities.
The creation of this internationally-competitive centre incorporating NHS, academic and industry partners will allow Glasgow to support a much greater volume and variety of clinical trials and translational development. All of benefit to the associated supply chain including the local Scottish company base of specialist CROs and other service providers.
Find out more about life science opportunities in Scotland